We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+25.91%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$41.3B
AUM Growth
+$4.26B
Cap. Flow
-$462M
Cap. Flow %
-1.12%
Top 10 Hldgs %
91.6%
Holding
1,678
New
553
Increased
134
Reduced
156
Closed
796

Sector Composition

Rank Sector Weight
1 Communication Services 0.07%
2 Consumer Discretionary 0.06%
3 Technology 0.02%
4 Healthcare 0.02%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPUH
1601
CALL
DELISTED
Compute Health Acquisition Corp.
CPUH
-3,800
Closed -$38.4K
CPUH
1602
DELISTED
Compute Health Acquisition Corp.
CPUH
-2,452
Closed -$24.8K
CPUH
1603
PUT
DELISTED
Compute Health Acquisition Corp.
CPUH
-9,700
Closed -$98K
AJRD
1604
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
-6,100
Closed -$341K
BBIG
1605
CALL
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-1,500
Closed -$13.9K
BBIG
1606
PUT
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-25
Closed -$232
VRAY
1607
CALL
DELISTED
ViewRay, Inc.
VRAY
-4,300
Closed -$19.3K
GLOP
1608
CALL
DELISTED
GASLOG PARTNERS LP
GLOP
-400
Closed -$2.66K
GLOP
1609
DELISTED
GASLOG PARTNERS LP
GLOP
-18,323
Closed -$122K
GLOP
1610
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
-21,900
Closed -$146K
STCN
1611
CALL
DELISTED
Steel Connect, Inc. Common Stock
STCN
-2,100
Closed -$28K
STCN
1612
DELISTED
Steel Connect, Inc. Common Stock
STCN
-214
Closed -$2.86K
STCN
1613
PUT
DELISTED
Steel Connect, Inc. Common Stock
STCN
-214
Closed -$2.86K
TCRR
1614
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-59,500
Closed -$59.4K
TCRR
1615
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-31,992
Closed -$32K
TCRR
1616
PUT
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-33,200
Closed -$33.2K
JNCE
1617
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-5,701
Closed -$6.33K
JNCE
1618
PUT
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-5,700
Closed -$6.33K
PRVB
1619
CALL
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-30,800
Closed -$326K
PRVB
1620
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-1,411
Closed -$14.9K
PRVB
1621
PUT
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-7,800
Closed -$82.4K
OIG
1622
CALL
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-88
Closed -$690
OIG
1623
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-286
Closed -$2.25K
OIG
1624
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-243
Closed -$1.91K
PEAR
1625
CALL
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-4,000
Closed -$4.72K

Similar funds

Belvedere Trading's Q1 2023 Portfolio in Review

As of Q1 2023, Belvedere Trading held 1,678 positions worth $41.3B, up 12% from $37B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Belvedere Trading's Q1 2023 filing shows 553 new, 134 increased, 156 reduced and 796 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M. The largest sale was Tesla, an estimated $80.1M.

By sector, the portfolio is most concentrated in Communication Services at 0.07% of assets, up from 0.02% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Belvedere Trading's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 279,308 shares worth $114M.
  • Belvedere Trading added most to Meta Platforms (Facebook) in Q1 2023, an estimated $14.6M increase.
  • Belvedere Trading's biggest Q1 2023 reduction was Tesla, cutting an estimated $80.1M.
  • Belvedere Trading fully exited Amazon in Q1 2023, selling an estimated $30.3M.
  • Belvedere Trading's ten largest holdings make up 92% of its $41.3B portfolio in Q1 2023.
  • Belvedere Trading opened 553 new positions and closed 796 in Q1 2023.
  • Belvedere Trading's portfolio value rose 12% quarter-over-quarter to $41.3B.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.